293 related articles for article (PubMed ID: 29490359)
21. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study.
Lähteenvuo M; Paljärvi T; Tanskanen A; Taipale H; Tiihonen J
Br J Psychiatry; 2023 Oct; 223(4):456-464. PubMed ID: 37395140
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: A 1-year retrospective cohort study.
Chan HW; Huang CY; Feng WJ; Yen YC
J Affect Disord; 2016 Nov; 205():360-364. PubMed ID: 27568173
[TBL] [Abstract][Full Text] [Related]
23. Association of pharmacological treatments and real-world outcomes in borderline personality disorder.
Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Acta Psychiatr Scand; 2023 Jun; 147(6):603-613. PubMed ID: 37094828
[TBL] [Abstract][Full Text] [Related]
24. Comparative Effectiveness of Antipsychotics in Preventing Readmission for First-Admission Schizophrenia Patients in National Cohorts From 2001 to 2017 in Taiwan.
Lin YH; Wu CS; Liu CC; Kuo PH; Chan HY; Chen WJ
Schizophr Bull; 2022 Jun; 48(4):785-794. PubMed ID: 35569004
[TBL] [Abstract][Full Text] [Related]
25. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Shesler LW; McElroy SL; Friedman ES; Thase ME; Shelton RC; Bowden CL; Tohen M; Singh V; Deckersbach T; Ketter TA; Kocsis JH; McInnis MG; Schoenfeld D; Bobo WV; Calabrese JR;
Clin Trials; 2014 Feb; 11(1):114-27. PubMed ID: 24346608
[TBL] [Abstract][Full Text] [Related]
27. Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia.
Taipale H; Tanskanen A; Luykx JJ; Solmi M; Leucht S; Correll CU; Tiihonen J
Schizophr Bull; 2022 Jun; 48(4):774-784. PubMed ID: 35524479
[TBL] [Abstract][Full Text] [Related]
28. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.
Nielsen J; Jensen SO; Friis RB; Valentin JB; Correll CU
Schizophr Bull; 2015 May; 41(3):627-36. PubMed ID: 25180312
[TBL] [Abstract][Full Text] [Related]
30. Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study.
Kadakia A; Dembek C; Liu Y; Dieyi C; Williams GR
J Med Econ; 2021; 24(1):1212-1220. PubMed ID: 34647502
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder.
Lintunen J; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J; Lähteenvuo M
Schizophr Bull; 2021 Jul; 47(4):1099-1107. PubMed ID: 33533399
[TBL] [Abstract][Full Text] [Related]
32. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Yatham LN; Fallu A; Binder CE
Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
[TBL] [Abstract][Full Text] [Related]
33. Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics.
Um YH; Kim TW; Seo HJ; Hong SC; Kim SM; Oh JH; Jeong JH
Int Clin Psychopharmacol; 2020 Sep; 35(5):263-269. PubMed ID: 32459726
[TBL] [Abstract][Full Text] [Related]
34. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
Vieta E; Günther O; Locklear J; Ekman M; Miltenburger C; Chatterton ML; Åström M; Paulsson B
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1029-49. PubMed ID: 21733231
[TBL] [Abstract][Full Text] [Related]
36. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study.
Chan HW; Huang CY; Feng WJ; Yen YC
Psychiatry Clin Neurosci; 2015 Aug; 69(8):497-503. PubMed ID: 25781185
[TBL] [Abstract][Full Text] [Related]
37. Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study.
Antolín-Concha D; Lähteenvuo M; Vattulainen P; Tanskanen A; Taipale H; Vieta E; Tiihonen J
J Affect Disord; 2020 Dec; 277():885-892. PubMed ID: 33065830
[TBL] [Abstract][Full Text] [Related]
38. Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study.
Toffol E; Hätönen T; Tanskanen A; Lönnqvist J; Wahlbeck K; Joffe G; Tiihonen J; Haukka J; Partonen T
J Affect Disord; 2015 Sep; 183():159-65. PubMed ID: 26005778
[TBL] [Abstract][Full Text] [Related]
39. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
Tien Y; Wang XY; Huang SC; Huang HP
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38696112
[No Abstract] [Full Text] [Related]
40. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study.
Kessing LV; Gerds TA; Feldt-Rasmussen B; Andersen PK; Licht RW
JAMA Psychiatry; 2015 Dec; 72(12):1182-91. PubMed ID: 26535805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
